First sign of improvement in oral iron therapy is?
**Core Concept:**
The question is testing the clinical sign or symptom that indicates an improvement in oral iron therapy. Iron is essential for haemoglobin synthesis, and iron deficiency anaemia is a common entity in clinical practice. Oral iron therapy aims to replace the deficient iron and improve the patient's haemoglobin levels and overall health.
**Why the Correct Answer is Right:**
The correct answer, **"Correct Answer: C. Increase in haemoglobin levels"**, reflects the primary endpoint of oral iron therapy - the improvement in haemoglobin levels. Haemoglobin is the protein found in red blood cells that carries oxygen. Haemoglobin's levels are directly proportional to the body's iron stores, and a decrease in haemoglobin levels is a clinical sign of iron deficiency anaemia. As oral iron therapy replenishes iron stores, the haemoglobin levels gradually increase, indicating therapeutic efficacy.
**Why Each Wrong Option is Incorrect:**
A. **"Increase in haematocrit levels"**: Haematocrit is another measure of red blood cell volume, but unlike haemoglobin, it is not directly proportional to iron stores. Hence, haematocrit increase may not indicate oral iron therapy's efficacy in treating iron deficiency anaemia.
B. **"Improvement in mucocutaneous lesions"**: Mucocutaneous lesions are indirect signs of iron deficiency anaemia, and improvement in these lesions does not necessarily reflect oral iron therapy's direct efficacy.
D. **"Reduction in serum ferritin levels"**: Serum ferritin is a marker of iron stores, but its decrease does not directly indicate oral iron therapy's efficacy. It may occur due to increased demand for iron or inflammation.
**Clinical Pearl:**
The question emphasizes the importance of monitoring and assessing therapeutic outcomes in clinical practice. In oral iron therapy for iron deficiency anaemia, assessing haemoglobin levels is crucial for evaluating the treatment's effectiveness. Monitoring haematocrit, serum ferritin, or mucocutaneous lesions may not adequately assess the treatment's direct efficacy.